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Case presentation
A 31-year-old black man was brought to the emergency ward of the
Massachusetts General Hospital after he was found unconscious on the
Boston Common. On examination, the patient was unresponsive, with
a blood pressure of 180/110 mm Hg and a pulse of 39 beats/mm (after
atropine, 120 beats/mm). His face and mouth were bloody from trauma.
Examination of the lungs, heart, and abdomen was unremarkable.
Rectal examination demonstrated decreased sphincter tone. On neuro-
logic examination, the patient displayed decerebrate posturing on the
left side and was flaccid on the right side, with a dilated and fixed left
pupil at 7 mm and a small but nonreactive right pupil at 3 mm.
Laboratory studies disclosed: serum sodium, 140 mEq/liter; potas-
sium, 3.9 mEq/liter; chloride, 105 mEq/liter; and bicarbonate, 29
mEq/liter. The BUN was 11 mg/dl and creatinine 1.1 mg/dl. The blood
sugar was 96 mg/dl; LDH, 256 U/liter; CPK, 897 U/liter; and ethanol
level, 152 mgldl. Hematocrit was 47.8%; white blood cell count,
22,100/mm3; and platelets, 190,000/mm3. Prothrombin time, partial
thromplastin time, and urinalysis were normal. The patient was intu-
bated, hyperventilated, and given mannitol. Chest and cervical spine
x-rays were negative. A CT scan of the head showed a left subdural
hematoma with diffuse edema involving the left cerebral hemisphere
and a significant shift from left to right of the midline structures.
The patient was taken to the operating room for a craniotomy and
evacuation of a left frontotemporal parietal subdural hematoma; an
intracranial pressure bolt was inserted. After surgery the patient's
pupils became equal and reactive to light. The patient was transferred to
the neurosurgical intensive care unit, where he was treated with
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dexamethasone and mannitol; hyperventilation was induced. The pa-
tient remained comatose for 2 weeks. The postoperative course was
complicated by aspiration pneumonia and a urinary tract infection.
Sputum and urine culture grew Enterobacter cloaca; ampicillin and
gentamicin resolved the signs and symptoms. A second CT scan of the
head, done one week after admission, showed no further bleeding, less
edema, resolution of the subdural hematoma, and resolution of the shift
away from the midline. Tracheostomy and gastrostomy were done
during the third week and the patient was given Osmolite and Ensure by
nasogastric tube. During the third week, the patient was able to move
his right hand purposefully but had a left hemiparesis. The serum
sodium began to fall gradually 3 weeks after the trauma, from 144
mEq/liter to 115 mEq/liter. Urine sodium was 30—87 mEq/liter when the
serum sodium was between 115—122 mEq/liter; the urine osmolality was
311 mOsm/kg H20. Cortisol and thyroid function tests were normal. No
seizure activity was noted.
A diagnosis of SIADH was made and fluid intake was restricted to
1200 ml/24 hr; the serum sodium remained at 120 mEq/liter. He was
then given demeclocycline, 1200 mg/day, and fluid restriction was
tightened (800 ml/24 hr); the serum sodium concentration gradually
rose. The patient was discharged to a chronic care facility when his
serum sodium concentration reached 130 mEq/liter. At the rehabilita-
tion hospital, the serum sodium continued to rise and eventually
stabilized at 137—142 mEq/liter. After one month, fluid restriction and
demeclocycline were discontinued. Serum sodium subsequently fell to
121 mEq/liter in one week. Fluid restriction and demeclocyclmne were
restarted and the serum sodium was maintained at 130—135 mEq/liter.
Discussion
DR. DENNIS AUSIELLO (Chief, Renal Unit, Massachusetts
General Hospital, and Associate Professor of Medicine, Har-
vard Medical School, Boston, Massachusetts): The patient
under discussion today demonstrated a syndrome characterized
by hyponatremia, probably the most common electrolyte ab-
normality found in a hospital population. Although there are
many causes of hyponatremia, the patient's clinical syndrome is
most typical of a hyponatremic state associated with a clinically
imperceptible change in the extracellular fluid volume that is
due to the inappropriate secretion of vasopressin. This syn-
drome can be caused by various tumors, many diseases of the
central nervous system, lung disease, and a variety of drugs.
Vasopressin is the major hormone involved in the regulation of
water balance by all mammals, including humans. Its action in
the renal collecting duct provides for acute and accurate adjust-
ment of water reabsorption as dictated by the needs of the
organism. In contrast, a surfeit (as in our patient) or lack of
vasopressin in pathophysiologic conditions results in severe
alterations in the state of hydration of an organism. Its mecha-
nism of action has been studied in the key target epithelium, the
renal collecting duct, as well as in two in-vitro models, the
amphibian skin and bladder. In general, vasopressin-sensitive
epithelia are remarkably impermeable to water in the resting
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Fig. I. Proposed pathway of water channel recycling in collecting duct principal cells. IMPs that are bejieved to represent water channels are
concentrated in clathrin-coated pits at cell surface and are endocytosed in coated vesicles. These vesicles are rapidly decoated, and while their
fluid-phase content may eventually reach multivesicular lysosomes, water channels themselves may escape degradation and be recycled to apical
membrane. The nature of vesicles carrying water channels to membrane has not been elucidated in collecting duct, nor have sites of fusion of these
vesicles at apical membrane been described in this tissue following vasopressin administration. (From Brown D: Membrane recycling and epithelial
cell function. Am J Physiol 256:Fl—F12, 1989.)
state, in contrast to the usual high permeability of luminal
membranes of other epithelial cells. When stimulated by vaso-
pressin, the permeability of the renal collecting duct and
amphibian skin and bladder increases to a level comparable
with that of most other biologic membranes. Vasopressin
induces this transformation in water permeability in its target
cells by first binding to its receptor on the basolateral surface of
the epithelial cell, stimulating adenylyl cyclase, and increasing
the cytoplasmic concentration of the second messenger, cyclic
AMP. Although the molecular events distal to cAMP produc-
tion are obscure, the resulting morphologic events have been
defined in the toad bladder and, to a lesser extent, in the renal
collecting duct.
Alterations in luminal membrane structure in response to
antidiuretic hormone were first demonstrated by freeze-fracture
electron microscopy by Chevalier et al [1]. They showed that,
within minutes after stimulation by antidiuretic hormone, ag-
gregates of small intramembranous particles (IMPs) appear in
the luminal membrane of frog bladder granular cells. Their
observation has been confirmed in a number of laboratories [for
review, see Refs. 2 and 3] and has been extended to the
collecting duct of the mammalian kidney [4] and to toad
epidermis [5]. A further understanding of this process came
from the work of Wade [6] and Humbert et a! [71,who reported
that thin, tubular structures in the apical cytoplasm of toad
bladder granular cells contain the IMP aggregates in a helical
array, and appear to deliver them to the luminal membrane after
vasopressin-induced fusion of the tubular structures containing
the IMPs with the apical plasma membrane (Fig. I). Wade et al,
in the "shuttle hypothesis," proposed that the cytoplasmic
tubular structures travel from sites in the apical cytoplasm to
the luminal membrane and return [8]. In support of this hypoth-
esis, they demonstrated that the frequency of these structures
in the cytoplasm decreased after vasopressin stimulation, which
suggested that these structures had migrated to fusion sites in
the membrane. Muller and colleagues advanced the idea of
vasopressin-induced fusion further by showing that fusion
events were rare in the absence of vasopressin and that they
increased sharply in the presence of hormone [91. Thus, the
final steps in the action of vasopressin seem to be a special case
of fusion by exocytosis, entirely in keeping with a hormonal
response that must appear and disappear rapidly as the state of
hydration of the subject changes.
In this discussion, I will review the phenomena of exocytosis
and endocytosis as they apply to vasopressin's action, and I will
demonstrate how these phenomena can be used to develop a
functional assay for the so-called water channel in endosomes
from renal medullary collecting duct cells.
Membrane cycling of IMPS
In the toad bladder and the toad skin, a correlation exists
between vasopressin-induced osmotic water flow and IMP
cluster frequency in the apical membrane of vasopressin-sensi-
tive cells [5, 10]. Similarly, in the renal collecting duct, a
dose-response relationship exists between the vasopressin-
induced increase in urine osmolality and IMP cluster frequency
in the apical membrane of vasopressin-sensitive cells in Brat-
tleboro rats [11]. Although direct evidence is lacking, it is
presumed from the exquisite correlation between the presence
of the IMPs and the physiologic action of the hormone that the
IMPs within the clusters, in fact, serve as the water channels
across the previously impermeable membrane of these epithe-
hal cells. I will use the terms "IMPs" and "water channels"
interchangeably for the remainder of this discussion.
Brown and colleagues investigated the mechanisms of water
channel insertion and removal from the apical plasma mem-
branes of vasopressin target cells. They reasoned that if vesicle
shuttling were playing a role in the insertion and removal of
IMP aggregates from the apical membrane of the renal collect-
ing duct and the toad bladder, then specific morphologic corre-
lates of the endocytotic pathway might be identifiable. They
approached this problem by using membrane labeling tech-
niques to define structures that might include the IMPs. In the
collecting duct [12], as well as in the toad bladder [13], they
found that the IMP aggregates were not labeled with filipin-
sterol complexes, in contrast with the heavy labeling of the rest
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Fig. 2. Luminal plasma membranes of collecting-duct principal cells from Brattleboro rats that had received I U of vasopressin tannate in peanut
oil, subcutaneously, for 4 consecutive days. Figs. 2A and 2B are freeze-fracture replicas, whereas Fig. 2C is a thin section. Vasopressin treatment
induces the appearance of IMP clusters (arrowheads, Fig. 2A) on these membranes, in parallel with an increase in urine osmolality. When
vasopressin-treated kidneys are exposed to filipin before fracture, the typical filipin-sterol complexes are abundant in the apical membrane, but are
absent from the IMP clusters (arrowheads, Fig. 2B). This property can be used to identify the IMP clusters in thin sections, because most of the
apical membrane is disrupted by the filipin (Fig. 2C), whereas the regions corresponding to the clusters retain a trilaminar membrane structure.
In Fig. 2C three such regions are present (arrows) and they all correspond to coated pits. In this way, the vasopressin-induced IMP clusters were
identified as being present in coated pits (Bar, 0.5 sm).
of the plasma membrane (Figs. 2A, B, C). Filipin is a sterol- tions within the membrane that are easily visible in both
specific antibiotic used as a cytochemical probe for membrane freeze-fracture and thin-section electron microscopy. Vaso-
cholesterol and related /3-hydroxy sterols. It produces deforma- pressin-induced IMP aggregates are shown in Figure 2A in the
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luminal membrane of collecting-duct principal cells from Brat-
tleboro rats that had been treated with vasopressin, Figure 2B
illustrates a similar membrane region, but it is from a sample of
tissue that had been pre-incubated with filipin before freeze-
fracturing. The small bumps, characteristic of filipin-sterol
complexes, are visible throughout the membrane, but these are
absent from many circular or oval regions, marked with arrow-
heads, which correspond to the IMP aggregates. This absence
of filipin-sterol complexes made it possible to identify the IMP
aggregates in thin sections of the collecting duct because they
retained a trilaminar appearance while the rest of the membrane
was disrupted by the filipin-sterol complexes (Fig. 2C). In this
way, the particle aggregates in the collecting duct were found to
correspond to "coated pits," structures that are involved in
receptor-mediated endocytosis in other cell types [14].
Coated pits are membrane domains that contain a coat of
protein, known as clathrin, on their cytoplasmic surface. The
role of this protein in the function of the coated pit is uncertain,
but it is probably involved in controlling endocytosis. When
Brattleboro rats, which genetically lack vasopressin, were
treated with this hormone, a tenfold increase in coated pits was
measured in collecting duct principal cells, concomitant with
the appearance of freeze-fracture aggregates [121. It therefore is
probable that the membrane domains containing the IMP ag-
gregates are selectively removed from the apical plasma mem-
brane by internalization via coated pits. Indeed, Brown et al
recently showed that vasopressin stimulates a large increase in
the endocytotic uptake of horseradish peroxidase by principal
cells in Brattleboro rats, and that this endocytotic uptake
occurs via coated pits [15]. How the aggregates are recycled
back to the apical membrane has not yet been determined in the
collecting duct. After coated pits are endocytosed and form
coated vesicles, the clathrin coat is rapidly removed to form
smooth vesicles. Thus with time the endocytosed IMPs appear
in smooth vesicles loaded with horseradish peroxidase because
of rapid decoating of the endocytosed clathrin-coated vesicles
[16]. Alternatively, clathrin-coated vesicles can fuse with non-
coated vesicles, as in the toad bladder [17], followed by
decoating of the clathrin. It is therefore unlikely that the
reinsertion of these clusters via a shuttle mechanism involves
clathrin-coated vesicles. If, then, vasopressin induces exocyto-
sis of smooth vesicles containing water channels (IMP clusters),
when do the inserted clusters become associated with clathrin
in the apical membrane? Virtually all the clusters appear in
coated pits, so this must be a very rapid event, if the clusters are
inserted intact into the membrane via smooth-vesicle fusion. If
we assume that the IMP clusters found in the membrane
represent only one-half of the cycle—the endocytotic half—and
that during vasopressin's action in the collecting duct, water
channels are inserted into the membrane in a form that is
morphologically not easily detectable (that is, non-clustered),
then these channels would cluster into coated pits only prior to
internalization, and only at this time do they become morpho-
logically distinct from other IMPs in the plasma membrane. If
this is the case, this clustering into coated pits could be
associated with the permeability of this channel; on the other
hand, individual channels could be active" even when dis-
persed throughout the membrane. (See Fig. 1 for summary of
this process.)
The events involved in cluster formation in the membrane
Fig. 3. Endocytosis of carboxyfluorescein (CF) by cortical and papillaiy
renal tubular cells from Brattleboro rats in the absence (minus VP) or
presence (plus VP) of vasopressin. Cortical tubules constitutively
endocytose filtered CF (shaded vesicles). Two populations of cortical
endosomes are shown: at least one population contains vasopressin-
insensitive water channels known to be present in proximal tubule
membranes [21, 22]. In the absence of vasopressin, papillary endo-
somes containing water channels (studded clear vesicles) are not
actively cycling and thus do not endocytose CF. Some constitutive
endocytosis of CF does occur into endosomes (shaded vesicles) that
demonstrate only diffusional water flow. In the presence of vasopressin,
papillary vesicles containing water channels are cycled, with the
endocytic pathway involving coated pits (bars on invaginated vesicles).
This results in a population of papillary vesicles containing CF and
water channels (studded shaded vesicles). (The characteristics of water
permeability in these vesicles are described in Table 1 and in Figs. 4 and
5).
currently are being investigated in renal epithelia in our labora-
tory. One problem we face is the difficulty in unambiguously
identifying cluster-bearing cytoplasmic vesicles in principal
cells. Unlike the situation in the toad bladder, where such
vesicles can be readily identified because of the tight, almost
paracrystalline packing of the IMP clusters on the vesicle-
limiting membrane [8], the clusters of IMPs in the kidney are
much looser in structure and cannot be easily distinguished
from intramembranous particles of any source that are abun-
dant in vesicles of small diameter; that is, there does not appear
to be a unique clustering or structure of IMPs in the renal
vesicles that can be defined as those involved in water channel
activity.
Measuring the water permeability of isolated endocytosed
vesicles from the kidney
One prediction that follows from these observations is that
the membrane domains that are internalized via coated pits
during vasopressin's action should be rich in water channels
and, therefore, should show permeability characteristics com-
patible with the presence of rapid, bulk water flow (see Fig. 3
for description of the hypothesis). In collaboration with Dr.
Alan Verkman at the University of California at San Francisco,
Minus VP Plus VP
Cortex (proximal tubule)
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Fig. 4. Time course of osmotic water transport in endocytotic vesicles containing 6-carboxyfluo'-escein (6CF). Brattleboro rats dehydrated for 12—22
hours were infused with a bolus of 5.7mg 6CF with and without 1.4 tg vasopressin over 1 mm and were sacrificed after 15 mm. The kidneys were
removed immediately and the entire papilla and superficial cortex were dissected in 50 mM mannitol and 5 mM sodium phosphate at pH 8.5 at 4°C;
endosomes were prepared. Endosomes (50 tg protein/mi) were mixed with an equal volume of buffer containing 50mM mannitol, 200mM sucrose,
and 5 mM sodium phosphate at pH 8.5 to generate a 100 mOsm/kg H20 inward sucrose gradient in a Hi-Tech stopped-flow apparatus (dead time
<2 msec) interfaced to a MINC/23 computer. Fluorescence was excited at 460 nm by a stabilized 100-watt tungsten source in series with a single
grating monochromator and a 450—490 nm 6-cavity interference filter. Emission was filtered through 2 Schott glass 0G515 cut-on filters. There was
no detectable scattered light under these conditions. Each curve in Fig. 4 is the average of four individual experiments performed at 21°C. The first
100 msec of the curves of the upper half of the figure were expanded and shown in the lower half of the figure; curves were displaced in the
y-direction to demonstrate the parallel time courses of the slow exponential processes. In papillary vesicles plus vasopressin (+VP), the drop in
fluorescence within the initial 100 msec indicates the presence of a fast component that was not present in papillary vesicles without vasopressin
(—VP) (or in cortical vesicles with or without vasopressin). Biexponential fits (thin beaded lines) are shown through the data; time constants and
pre-exponential factors are summarized in Table 1.
we recently tested this prediction in a crude microsomal frac-
tion of renal papilla [18].
To isolate vesicles for analysis of water permeability, ho-
mozygous Brattleboro rats with hereditary diabetes insipidus
[19] were infused intravenously with 6-carboxyfluorescein
(6CF) with and without vasopressin. A membrane-impermeant,
fluid-phase marker of endocytosis, 6CF, filters freely through
the glomerulus and is taken up via endocytosis by cells lining
the urinary tubule, including the proximal tubule and renal
collecting duct (Fig. 3). A crude microsomal pellet containing
these endocytotic vesicles with entrapped 6CF was obtained by
homogenization of cortical and papillary tissue and differential
centrifugation. The osmotic water permeability of 6CF-labeled
endocytotic vesicles was measured by the time course of
decreasing 6CF fluorescence following mixture of microsomal
vesicles with hyperosmotic buffer to yield a 100 mM inward
osmotic gradient (Fig. 4).
As water efflux occurs, the concentration of entrapped 6CF
increases, resulting in a decrease in fluorescence intensity due
to self-quenching. The time course of this process, together
with other characteristics referred to later (activation energy,
Ea, and water permeability coefficient, Pf) make it possible to
distinguish between transmembrane water movement by lipid
diffusion and by bulk flow through water channels. The water
permeability characteristics of subcellular vesicles that are not
involved in endocytosis and thus never contained 6CF are not
measured in this fluorescent assay.
Vasopressin dramatically alters the kinetics of osmotic water
effiux in endosomes from renal papilla (Table 1), which consist
almost entirely of endosomes from the vasopressin-sensitive
collecting tubule [15]. In endosomes from animals not receiving
vasopressin, the time course of decreasing fluorescence is fitted
by a single exponential function (time constant 1.03 sec),
indicating the presence of vesicles with a single functional water
permeability. In contrast, a biexponential function is required
to fit the fluorescence curve in endosomes from animals treated
with vasopressin, indicating the presence of at least two popu-
lations of labeled vesicles. In addition to a population of
vesicles with a slow rate of water effiux (1.06 sec), a second
population of papillary endosomes has a fast rate of water effiux
(0.040 sec). As expected, vasopressin had no effect on water
transport in endosomes isolated from renal cortex, the bulk of
which are found in vasopressin-insensitive membranes from
proximal tubule [20]. Cortical endosomes with rapid water
Nephrology Forum: The water channel 501
Cortical
vesicles
is
+ VP
Papillary
vesicles
is
a)
C)C
a)
a)
0
U.. — VP
+VP
— VP
100 ms
I-
+VP
—VP
502 Nephrology Forum: The water channel
Fractional
fast
Time constant (s) component
Slow
Fast process process
Cortical endosomes
— Vasopressin 0.042 0.002 0.76 0.04 0.62 0.02
+ Vasopressin 0.042 0.002 0.80 0.05 0.61 0.03
Papillary endosomes
— Vasopressin Not present 1.03 0.07 0
+ Vasopressin 0.040 0.004 1.06 0.08 0.44 0.03
Results are mean SE for measurements performed on 6 separate
preparations of cortical and papillary endosomes from Brattleboro rats.
For each sample, water permeability was measured in quadruplicate
and fitted to biexponential functions as in Fig. 4. The fractional fast
component is the ratio of the pre-exponential factor for the fast-time
component to the total signal amplitude.
transport result from constitutive (vasopressin-independent)
endocytosis of water channels known to be present in proximal
tubule membranes [21, 221. These data indicate that vasopressin
induces a cellular process in the renal papilla resulting in the
appearance of 6CF-labeled endosomes in which the limiting
membranes contain water channels (Fig. 3).
To demonstrate that in our assay the appearance of a water
channel in papillary endosomes was a direct effect of vasopres-
sin and not an indirect effect of either urine osmolality, 6CF
concentration, vascular effects, or endosome geometry, we
dehydrated Brattleboro rats for 12 to 22 hours and subjected the
animals to ureteral catheterization to measure the urine osmo-
lality and 6CF concentration. In the dehydrated rat, which
concentrates its urine in a vasopressin-independent manner
[23], vasopressin had no further effect on urine osmolality (+VP
560 90 mOsmlkg H20, mean SD; —VP 549 100 mOsm/kg
H20, n 4) or on 6CF concentration (+VP 34 8 mM, —VP
32 2 mM), but it still induced the appearance of endosomes
containing fast-water channels. To show that the vasopressin
effect was unrelated to vascular effects, we infused the specific
V2 agonist, 1-D-amino-8-D-Arg-vasopressin (DDAVP, 5—60
U/min/100 g wt) into Brattleboro rats dehydrated for 18 to 22
hours. A rapid component of water transport was induced by
DDAVP in papillary endosomes, similar to the results we had
obtained with vasopressin; water transport in cortical endo-
somes was not affected.
To determine endosome size, we injected rats with 6 mg
horseradish peroxidase with and without vasopressin. Microso-
mal fractions were fixed, reacted with diaminobenzidine and
H202, and visualized by thin-section electron microscopy.
Vasopressin had no effect on the size distribution of horseradish
peroxidase-positive vesicles, which showed a unimodal gaus-
sian distribution of vesicle diameter, with a mean of 110 24
nm. To show that 6CF entered a population of vesicles only by
endocytic uptake, we infused 12 mg of fluorescein-dextran (4
kDa) in place of 6CF to label endosomes with a high-molecular-
weight, membrane-impermeant fluorophore. Rates of water
efflux and the vasopressin effect were identical to those ob-
tained in endosomes labeled with 6CF.
3.3 3.4 3.5
1000/1, °K'
Fig. 5. Arrhenius plot for osmotic water transport in papillary endocy-jotic vesicles. Measurements were performed (as described in the
legend to Fig. 4) at varying temperatures. Each point is the mean SD
for measurements performed in quadruplicate. Data were fitted to single
activation energies indicated, Open circles indicate data obtained from
vesicles from animals not exposed to vasopressin. In this situation (see
text), only slow water movement with a high energy activation is found.
In contrast, the closed circles indicate data obtained from vesicles from
rats exposed to vasopressin. In this case, two populations of vesicles
are found, those having slow water movement with a high energy of
activation, and those having a rapid water movement with a low energy
of activation.
To show that the fast, vasopressin-inducible component of
water efflux from endosomes is due to the presence of a water
channel, we determined the Ea and P for endosomal water
transport. An Ea greater than 10 kcallmole is associated with
slow, diffusive water movement, whereas an Ea less than 5
kcallmole implicates fast water movement via a channel [24]. In
papillary endosomes (Fig. 5), the Ea was 13 kcal/mole for the
slow component in vasopressin-treated and -untreated animals.
The Ea for the fast component, present only in the vasopressin-
treated animals, was 3.8 kcal/mole. For the fast component of
water transport in papillary endosomes from vasopressin-
treated animals, the calculated Pf was 0.03 cm/sec at 21°C,
based on a 110 nm vesicle diameter. This value is higher than
the Pf in lipid bilayers (0.0001—0.005 cm/see) [251 and is com-
parable to the Pf in red cells (0.02 cm/see) [26] and in the
vasopressin-stimulated renal collecting duct (0.01—0.02 cm/see)
[27, 28]. The high P and low Ea for the fast component of water
transport in papillary endosomes isolated from vasopressin-
treated animals indicate bulk water movement through channels
[241.
These experiments provide direct evidence for a vasopressin-
sensitive population of subcellular endocytotic vesicles that
contain water channels. The ability of vasopressin to induce the
appearance of these vesicles in the endocytic compartment of
responsive tissue strongly supports the hypothesis that vaso-
pressin initiates the cycling of functional water channels be-
tween the apical membrane and the endosomal compartment.
The recycling of these channels probably accounts for the
regulatory effect of vasopressin on apical plasma membrane
water permeability in target epithelia.
Table 1. Osmotic water transport in endocytotic vesiclesa
3 - +VP; 3.8 kcal/mole
2-
3.1 3.2
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Future prospects
Membrane domains containing a functional water channel
now have been identified, but we still do not know the nature of
this channel. Although the water channel is likely to comprise
one or more specific proteins, less specific protein-lipid inter-
actions within the IMP aggregates might account for the in-
creased permeability of these membrane domains. Our work
therefore is aimed at the isolation of vesicles containing IMP
aggregates, so that their biochemical composition can be estab-
lished.
Questions and answers
DR. NIc0LA0s E. MADIAS (Chief, Division of Nephrology,
New England Medical Center, Boston): Animal and human
observations indicate that, despite continued administration of
vasopressin and water, persistent retention of water ceases and
an "escape" phenomenon supervenes. Do the new insights on
the vasopressin receptor-cyclase system and the water channel
allow an understanding of this phenomenon?
DR. AusIELL0: The "escape" phenomenon might be charac-
terized by alterations in the vasopressin response at multiple
sites. These changes can include the desensitization of the
vasopressin receptor interaction with adenylyl cyclase, as we
have previously demonstrated [291. In addition to this desensi-
tization of the signal transduction mechanism, it is possible that
a change in the exocytotic or endocytotic rate of water channel
cycling, as I have just described, could occur and result in a
diminished response to the hormone. Since we are only begin-
ning to understand the steady-state kinetics of the exocytotic
and endocytotic cycle, these possibilities remain to be defined.
We first must be able to describe the biochemical and morpho-
logic correlates of stimulation of the water channel movement
and its removal before we can define whether these processes
are interrupted and whether that interruption leads to a de-
crease in vasopressin action in the "escape" phenomenon.
DR. JEROME P. KASSIRER (Associate Physician-in-Chief, De-
partment of Medicine, New England Medical Center): Do we
know whether individual cells of the collecting duct have
specialized functions? We know that the intercalated cells are
specialized to secrete hydrogen, and the cells containing coated
pits transport water. Do the cells containing coated pits also
transport other substances? For example, I presume they are
transporting urea, because urea and water transport are so
closely linked. Are there other functions in these cells as well?
DR. AUSIELLO: Yes, you have defined one of the more
interesting characteristics of the kidney, that is, its functional
heterogeneity between cells adjacent to each other. In the case
of the renal collecting duct, cells that have the coated pits
involved in the movement of water channels also have the
capacity to transport sodium through an amiloride-sensitive
sodium channel on the apical membrane, and urea through a
separate pathway also localized on the apical membrane. Both
these pathways, however, are distinct from the water channel.
The water channel is thus highly specific, and presumably its
cycling is unique to the collecting duct. We have no direct
evidence that the sodium channel or the urea channel or carrier
are also cycling in the same vesicles containing the water
channel.
DR. JOHN T. HARRINGTON (Chief of Medicine, Newton-
Wellesley Hospital, Newton, Massachusetts): Arginine vaso-
pressin has a number of other intracellular effects in addition to
its effect on the water channel. When one solitary vasopressin
molecule connects with the receptor, how does the receptor
know whether to tell the water channel to go into action or to
tell another intracellular function to become activated?
DR. AusIELL0: It is quite clear that when a receptor is
occupied by its ligand, in this case vasopressin, it couples to a
universal signal-transducing mechanism such as adenylyl cy-
clase and generates the second messenger, cAMP. Thus, the
specificity of action of a hormone at the cellular level is not
dictated by the second messenger that it generates, but rather
by the pathways distal to the second messenger that may be
unique to a given cell type. We normally associate the actions of
cAMP with the activation of protein kinase and the eventual
phosphorylation of one or more proteins involved in the phys-
iologic pathway. These remain to be defined for the induction of
the hydro-osmotic effect of vasopressin, so we cannot state
where the level of specificity arises in the renal collecting duct.
At this time, however, we can assume that the level of speci-
ficity for other cellular actions, either in the same cell type or in
different cell types where vasopressin might also raise cAMP
levels but induce ion transport, for example, will likely be
determined by what particular protein substrates are phosphor-
ylated and are available in the physiologic pathway.
DR. MADIAs: Is it certain that the entire receptor-G protein-
cyclase complex is intramembranous, or might part of it be
cytoplasmic?
DR. AusIELL0: It is certain that the receptor and catalyic unit
are true intramembranous proteins. The G-protein complex
involves a heterotrimer that is made up of a, /3, and y subunits
[29—311. These subunits have both hydrophobic and hydrophilic
regions. The current hypothesis is that the /3 and y subunits are
the main anchoring subunits of 0 proteins, and the a subunit is
clearly membrane attached. The a subunit might have a signif-
icant portion of its hydrophilic region extending into the cyto-
plasm for interaction with the cytoplasmic components of
receptors and effector proteins, such as the catalytic unit of
adenylyl cyclase. It does appear to be true, however, that the
complex of hormone receptor, G proteins, and catalytic unit of
adenylyl cyclase are capable of operating within membranous
microdomains.
DR. RONALD D. PERRONE (Division of Nephrology, New
England Medical Center): You indicated that water channels
are found in proximal tubules adjacent to the apical membrane
and that these channels are not regulated by vasopressin. Do
you have any information about how they are regulated and
whether they participate in glomerular tubular balance?
DR. AuslElLo: Dr. Alan Verkman at the University of
California at San Francisco recently published work demon-
strating the presence of water channels in both the apical and
basolateral membranes of the proximal tubule [32, 331. To my
knowledge there are no data available that deal with the
regulation of these water channels. However, the data that I
have presented with regard to our work in collaboration with
Dr. Verkman do suggest that these channels in the proximal
tubule membranes are capable of being endocytosed into vesi-
des [18]. How this phenomenon is regulated by the cell remains
to be elucidated.
DR. MADIAS: I believe there is an animal model of nephro-
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genie diabetes insipidus. Is there any information about the
cellular basis for this defect?
DR. AuSIELL0: Drs. Brown, Valtin, and colleagues have
published work during the last several years with this mouse
model of diabetes insipidus [351. These mice have a deficit in
their ability to form the intramembranous particle aggregates
that I described. Therefore, the defect very well might be in the
regulation of the insertion or removal of the IMPs. The bio-
chemical step that might be involved in this defect remains to be
defined, however.
DR. HARRJNGTON: Do you have any preliminary information
on the detailed structure and composition of the water channel
itself?
DR. Au5IELL0: We have no information as of yet.
DR. MADIAS: Could you briefly address our current under-
standing of the urine-concentrating defect associated with lith-
ium, hypercalcemia, and hypokalemia?
DR. AusIELL0: The urinary concentrating defects associated
with lithium, hypercalcemia, and hypokalemia can involve a
number of biochemical and cell biologic processes. For exam-
ple, it is now known that lithium may compete for magnesium in
the activation of G proteins that are required for coupling of
hormone receptors to the catalytic unit of adenylyl cyclase [36].
Thus, lithium is capable of blocking signal transduction induced
by vasopressin. Lithium might have multiple effects, however.
It also can block the dephosphorylation of inositol phosphates
(potentially important in the calcium and protein kinase C signal
transduction pathways) [37]. To the extent that these pathways
are involved in the hydroosmotic response, this may be an
additional site of lithium action.
The mechanism by which hypercalcemia inhibits the vaso-
pressin-induced hydroosmotic response is less clear. It has
been known for years that increasing calcium concentration can
lead to an inhibition of adenylyl cyclase [38]. What is unclear,
however, is whether modest increases in plasma calcium reflect
a significant increase in cytoplasmic calcium levels sufficient to
alter adenylyl cyclase activity. In some experimental animal
models, this is thought to be the case [391. Interestingly, this
inhibition might be mediated through the inhibitory guanine
nucleotide regulatory protein [40]. Elevations in calcium also
might stimulate prostaglandin synthesis, and prostaglandins are
known antagonists of vasopressin action [41, 42]. Since the cell
biology of vasopressin action involving endo- and exocytosis is
almost certainly linked to calcium, it would not be surprising if
subtle changes in intracellular calcium alter microtubule or
microfilament organization and derail" the shuttling of vesi-
des containing water channels. Until these mechanisms are
clearly identified, the exact role for calcium in the mediation or
inhibition of these processes remains to be defined.
The inhibitory effect of hypokalemia is equally poorly de-
fined. It might have less to do, however, with signal transduc-
tion than with membrane transport phenomena. In cells in
culture, for example, solutions containing low potassium can
prevent endocytosis [43]. What a low potassium level does to
exocytosis is unclear. Possibly, altered membrane potential or
altered intracellular enzyme activity, both known consequences
of a lowered extracellular potassium, might affect the cell
biology of vasopressin's action.
DR. HARRINGTON: Could you tell us more about the possible
mechanisms involved in the production of hypertonic urine by
the ADH-deficient Brattleboro rat?
DR. AustElLo: In the Brattleboro rat, which lacks vasopres-
sin, Valtin and others have shown that a dehydrated animal can
increase its urine osmolality significantly above that of plasma
[23]. Clearly, hemodynamic changes play some role in the
ability of this model to increase urine osmolality. Also of
interest, however, is the role of other hormones, such as
oxytocin. Valtin and colleagues have demonstrated that in
dehydrated Brattleboro rats, there is a rapid and significant rise
in serum oxytocin, which can interact with vasopressin recep-
tors and thus stimulate the hydroosmotic response. A role for
other hormones also has been suggested by the work of
DeRouffignac and colleagues [44]. Utilizing endocrine ablation
techniques, they have been able to establish that, in the absence
of vasopressin, other peptide hormones such as calcitonin
might be capable of mimicking some of vasopressin's action. It
thus appears likely that in the absence of vasopressin, the
combination of hemodynamic factors and other hormonal stim-
uli could contribute to significantly raised urine osmolality.
DR. PERRONE: At what cellular location does demeclocycline
act?
DR. AUSIELLO: Studies several years ago demonstrated that
demeclocycline could alter cAMP metabolism in vasopressin-
sensitive tissue [45]. I am not aware of any recent studies that
have defined its site of action with regard to the various
subunits involved in signal transduction. However, demeclocy-
dine also can interact with a number of calcium and calmodulin
binding sites [46]. This provides the opportunity for a number of
calcium-sensitive pathways to be altered, as I have already
alluded to; these alterations could include endo- and exocytosis
and microtubule or microfilament organization. Any or all of
these phenomena could change hormonal action.
DR. AJAY K. SINGH (Fellow in Nephrology, New England
Medical Center): Given that normal pregnancy is accompanied
by a mild state of hyponatremia, has the cellular water channel
been studied in pregnancy?
DR. AusIELL0: Water channel activity, as I have described it
in this discussion, has not been studied in pregnancy in humans.
But a significant body of information has been amassed con-
cerning the role of vasopressin and the hypoosmolality attend-
ing pregnancy. I know of no significant data at the cellular level
that implicate an overactivity of vasopressin's action and that
could account for the 8 or 10 milliosmolar decrease in plasma
osmolality observed in pregnant women. Not surprisingly, the
role of many hormones has been investigated, but to my
knowledge no one has determined that any hormones cause
hypoosmolality during pregnancy.
DR. HARRINGTON: I'd like to return to today's patient, in
whom a presumably considerable amount of circulating arginine
vasopressin accounted for his hyponatremia. Are there any
functional abnormalities other than water retention that we can
attribute to ADH in such a patient?
DR. AUsIELL0: That is an intriguing question. Although
vasopressin has actions at many sites throughout the body—
including vascular smooth muscle, platelets, liver, and brain, in
addition to its multiple actions in the kidney—we do not usually
attribute alterations in these organs' function to sustained high
levels of vasopressin that can occur in SIADH. Perhaps we do
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not look effectively enough; possibly these other processes are
under a variety of controls, such as the regulation of blood
pressure, and that even a sustained influence of vasopressin is
insufficient to deregulate the system. It is clear, however, that
when one isolates the system, such as vascular smooth muscle
or platelets, the effect of vasopressin on vascular contraction or
platelet aggregation is clearly demonstrable. My guess is that if
we were to study the patients with SIADH, we might demon-
strate some abnormalities in other areas that might, or might
not, be clinically significant.
DR. PERRONE: As you indicated, the principal cells of the
cortical collecting duct transfer sodium in addition to water.
Does aldosterone affect membrane recycling in these cells?
DR. AUSIELLO: To my knowledge, aldosterone has no direct
effect on the membrane cycling of water channels. Synergistic
effects between aldosterone and vasopressin do exist; these
have been described best in the toad urinary bladder [47]. In
that tissue, aldosterone seems to alter phosphodiesterase activ-
ity and increase vasopressin's ability to stimulate cAMP.
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